title: Endoscopist-directed administration of propofol: a worldwide safety experience.
abstract: OBJECTIVE
  Endoscopist-directed propofol sedation (EDP) remains controversial. We sought to update the safety experience of EDP and estimate the cost of using anesthesia specialists for endoscopic sedation.
  
  
  METHODS
  We reviewed all published work using EDP. We contacted all endoscopists performing EDP for endoscopy that we were aware of to obtain their safety experience. These complications were available in all patients: endotracheal intubations, permanent neurologic injuries, and death.
  
  
  RESULTS
  A total of 646,080 (223,656 published and 422,424 unpublished) EDP cases were identified. Endotracheal intubations, permanent neurologic injuries, and deaths were 11, 0, and 4, respectively. Deaths occurred in 2 patients with pancreatic cancer, a severely handicapped patient with mental retardation, and a patient with severe cardiomyopathy. The overall number of cases requiring mask ventilation was 489 (0.1%) of 569,220 cases with data available. For sites specifying mask ventilation risk by procedure type, 185 (0.1%) of 185,245 patients and 20 (0.01%) of 142,863 patients required mask ventilation during their esophagogastroduodenoscopy or colonoscopy, respectively (P < .001). The estimated cost per life-year saved to substitute anesthesia specialists in these cases, assuming they would have prevented all deaths, was $5.3 million.
  
  
  CONCLUSIONS
  EDP thus far has a lower mortality rate than that in published data on endoscopist-delivered benzodiazepines and opioids and a comparable rate to that in published data on general anesthesia by anesthesiologists. In the cases described here, use of anesthesia specialists to deliver propofol would have had high costs relative to any potential benefit.
authors: Division of Gastroenterology/Hepatology, Indiana University Medical Center, Indianapolis, Indiana 46202, USA. drex@iupui.edu
authors: Douglas K
authors: DK
authors: Rex
authors: Viju P
authors: VP
authors: Deenadayalu
authors: Emely
authors: E
authors: Eid
authors: Thomas F
authors: TF
authors: Imperiale
authors: John A
authors: JA
authors: Walker
authors: Kuldip
authors: K
authors: Sandhu
authors: Anthony C
authors: AC
authors: Clarke
authors: Lybus C
authors: LC
authors: Hillman
authors: Akira
authors: A
authors: Horiuchi
authors: Lawrence B
authors: LB
authors: Cohen
authors: Ludwig T
authors: LT
authors: Heuss
authors: Shajan
authors: S
authors: Peter
authors: Christoph
authors: C
authors: Beglinger
authors: James A
authors: JA
authors: Sinnott
authors: Thomas
authors: T
authors: Welton
authors: Magdy
authors: M
authors: Rofail
authors: Iyad
authors: I
authors: Subei
authors: Rodger
authors: R
authors: Sleven
authors: Paul
authors: P
authors: Jordan
authors: John
authors: J
authors: Goff
authors: Patrick D
authors: PD
authors: Gerstenberger
authors: Harold
authors: H
authors: Munnings
authors: Martin
authors: M
authors: Tagle
authors: Brian W
authors: BW
authors: Sipe
authors: Till
authors: T
authors: Wehrmann
authors: Jack A
authors: JA
authors: Di Palma
authors: Kaitlin E
authors: KE
authors: Occhipinti
authors: Egidio
authors: E
authors: Barbi
authors: Andrea
authors: A
authors: Riphaus
authors: Stephen T
authors: ST
authors: Amann
authors: Gen
authors: G
authors: Tohda
authors: Timothy
authors: T
authors: McClellan
authors: Charles
authors: C
authors: Thueson
authors: John
authors: J
authors: Morse
authors: Nizam
authors: N
authors: Meah
mesh_terms: D000758:Anesthesia / Q000009:adverse effects / Q000191:economics; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000009:adverse effects* / Q000191:economics; D002983:Clinical Competence; D003257:Consumer Product Safety; D003362:Cost-Benefit Analysis; D004724:Endoscopy / Q000191:economics; D014943:Global Health; D017048:Health Care Costs; D006801:Humans; D007442:Intubation, Intratracheal; D008397:Masks; D017410:Practice Guidelines as Topic; D015742:Propofol / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics; D012121:Respiration, Artificial / Q000295:instrumentation; D018570:Risk Assessment
chemical_list: D018686:Anesthetics, Intravenous; D015742:Propofol